Showing results (711-720 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|February 7, 2007
FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancerMarwan Ghosn, Fadi Farhat, Joseph Kattan, et al.
American Journal of Clinical Oncology|February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinomaRobert de W Marsh, C M Rocha Lima, D E Levy, et al.
American Journal of Clinical Oncology|February 7, 2007
Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinomaHyo Jin Lee, So Young Rha, Young Suk Jo, et al.
American Journal of Clinical Oncology|August 1, 1990
Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristineP Gill, M Rarick, M Bernstein-Singer, et al.
American Journal of Clinical Oncology|December 7, 2006
Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancerGilles Créhange, Mathieu Bosset, Fabrice Lorchel, et al.
American Journal of Clinical Oncology|December 7, 2006
Serial hypoxia imaging with 99mTc-HL91 SPECT to predict radiotherapy response in nonsmall cell lung cancerLing Li, Jinming Yu, Ligang Xing, et al.
American Journal of Clinical Oncology|December 7, 2006
The influence of race on the attitudes of radiation oncology patients towards clinical trial enrollmentCharles G Wood, S Jack Wei, Margaret K Hampshire, et al.
American Journal of Clinical Oncology|June 1, 2005
Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancerKimberly S Keene, Eloise M Harman, Daniel G Knauf, et al.
American Journal of Clinical Oncology|June 1, 2005
Phase I study of a weekly schedule of fixed-dose paclitaxel and escalating doses of cisplatin for recurrent or unresectable gastric cancer in JapanNaoto Takahashi, H Kashiwagi, S Iwabuchi, et al.
American Journal of Clinical Oncology|June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasoneCeleste Lindley, Susan Goodin, Jeannine McCune, et al.
Pageof 501